# Study on Anti-inflammatory Effects of Topical R115866 Gel

> **NCT00719121** · PHASE1 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 12 (actual)

## Conditions studied

- Cutaneous Inflammation

## Interventions

- **DRUG:** Talarozole
- **DRUG:** Differin™, 0.1% adapalene gel

## Key facts

- **NCT ID:** NCT00719121
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2006-12
- **Final completion:** 2007-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719121, "Study on Anti-inflammatory Effects of Topical R115866 Gel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00719121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*